These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 668778)

  • 1. Output of 14CO2 in breath after oral administration of (14C-methyl) aminopyrine in hepatitis, cirrhosis and hepatic bilharziasis: its relationship to aminopyrine pharmacokinetics.
    Noordhoek J; Dees J; Savenije-Chapel EM; Wilson JH
    Eur J Clin Pharmacol; 1978 May; 13(3):223-9. PubMed ID: 668778
    [No Abstract]   [Full Text] [Related]  

  • 2. Aminopyrine disposition: studies on breath, saliva, and urine of normal subjects and patients with liver disease.
    Hepner GW; Vesell ES
    Clin Pharmacol Ther; 1976 Dec; 20(6):654-60. PubMed ID: 991536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of drug metabolism in hepatic disease: comparison of plasma kinetics of oral cyclobarbital and the intravenous aminopyrine breath test.
    Breyer-Pfaff U; Seyfert H; Weber M; Egberts EH
    Eur J Clin Pharmacol; 1984; 26(1):95-101. PubMed ID: 6143671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of hepatic function by breath analysis after oral administration of (14C)aminopyrine.
    Hepner GW; Vesell ES
    Ann Intern Med; 1975 Nov; 83(5):632-8. PubMed ID: 1200495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminopyrine demethylation measured by breath analysis in cirrhosis.
    Bircher J; Küpfer A; Gikalov I; Preisig R
    Clin Pharmacol Ther; 1976 Oct; 20(4):484-92. PubMed ID: 975720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The determination of aminopyrin elimination for control of the metabolic capacity of the liver in man.
    Haustein KO; Hüller G; Sensing H
    Eur J Clin Invest; 1982 Apr; 12(2):157-64. PubMed ID: 6807687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited usefulness of the breath test in evaluation of drug metabolism: a study in human oral contraceptive users treated with dimethylaminoantipyrine and diazepam.
    Sonnenberg A; Koelz HR; Herz R; Benes I; Blum AL
    Hepatogastroenterology; 1980 Apr; 27(2):104-8. PubMed ID: 6783497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between the demethylation rate of 14C-aminopyrine (breath-test) and haemodynamic parameters in congestive heart failure.
    Pirotte J; El Allaf D; Carlier J
    Int J Clin Pharmacol Res; 1983; 3(6):485-9. PubMed ID: 6432713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between aminopyrine breath test and severity of liver disease in cirrhosis.
    Morelli A; Narducci F; Pelli MA; Farroni F; Vedovelli A
    Am J Gastroenterol; 1981 Aug; 76(2):110-3. PubMed ID: 6795921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of aminopyrine metabolism in man by breath analysis after oral administration of 14C-aminopyrine. Effects of phenobarbital, disulfiram and portal cirrhosis.
    Hepner GW; Vesell ES
    N Engl J Med; 1974 Dec; 291(26):1384-8. PubMed ID: 4427643
    [No Abstract]   [Full Text] [Related]  

  • 11. 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.
    Fasoli A; Giannini E; Botta F; Romagnoli P; Risso D; Celle G; Testa R
    Hepatogastroenterology; 2000; 47(31):234-8. PubMed ID: 10690614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The [14C]-aminopyrine breath test. A comparison of different forms of analysis.
    Henry DA; Sharpe G; Chaplain S; Cartwright S; Kitchingman G; Bell GD; Langman MJ
    Br J Clin Pharmacol; 1979 Dec; 8(6):539-45. PubMed ID: 533576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple method for routine determination of the metabolic liver capacity: the aminopyrine breath test.
    Haustein KO; Schenker E
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):190-6. PubMed ID: 3922902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14C-D-galactose breath test for evaluation of liver function in patients with chronic liver disease.
    Caspary WF; Schäffer J
    Digestion; 1978; 17(5):410-8. PubMed ID: 680418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of parent drug and metabolites in the intravenous aminopyrine breath test.
    Breyer-Pfaff U; Harder M; Egberts EH
    Eur J Clin Pharmacol; 1982; 21(6):521-8. PubMed ID: 6804246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of hepatic tetrahydrofolate and inhibition of exhalation of 14CO2 formed from [dimethylamino-14C]aminopyrine in nitrous oxide-treated rats.
    Black KA; Virayotha V; Tephly TR
    Hepatology; 1984; 4(5):871-6. PubMed ID: 6434391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid information provided by the 14C-aminopyrine breath test. Studies with 14C-monomethylaminoantipyrine in the guinea pig.
    Roots I; Nigam S; Gramatzki S; Heinemeyer G; Hildebrandt AG
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(2):175-8. PubMed ID: 6775236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis.
    Daneshmend TK; Homeida M; Kaye CM; Elamin AA; Roberts CJ
    Gut; 1982 Oct; 23(10):807-13. PubMed ID: 7117899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A [14C]phenacetin breath test to measure hepatic function in man.
    Breen KJ; Bury RW; Calder IV; Desmond PV; Peters M; Mashford ML
    Hepatology; 1984; 4(1):47-52. PubMed ID: 6420304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breath 14CO2 after intravenous administration of [14C]aminopyrine in liver diseases.
    Pauwels S; Geubel AP; Dive C; Beckers C
    Dig Dis Sci; 1982 Jan; 27(1):49-56. PubMed ID: 6802621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.